Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-03-23
1998-01-27
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 48, 536 2623, 536 2626, 536 267, A61K 3170, C07H 1920
Patent
active
057122580
ABSTRACT:
Purine-containing compounds that modulate cardiac muscle contractility are provided, as well as methods for modulating cardiac muscle contractility and receptors that bind the compounds.
REFERENCES:
patent: 4657898 (1987-04-01), Bristol et al.
patent: 4843066 (1989-06-01), Yamada et al.
patent: 4902677 (1990-02-01), Imai et al.
patent: 4990498 (1991-02-01), Suhadolnik
patent: 5017564 (1991-05-01), Makino et al.
patent: 5055304 (1991-10-01), Makino et al.
patent: 5104859 (1992-04-01), Sollevi
patent: 5140015 (1992-08-01), Olsson et al.
patent: 5219841 (1993-06-01), Inaba et al.
patent: 5246922 (1993-09-01), Kataoka et al.
patent: 5415873 (1995-05-01), Trepel et al.
patent: 5430027 (1995-07-01), Knutsen et al.
patent: 5516762 (1996-05-01), Bertics et al.
Kennedy, "P1-and P2-Purinoceptor Subtypes -An Update," Arch. Intl. Pharmacodynamie et de Therapie, 303, 30-50 (1990).
Williams, "Purine Receptors in Mammalian Tissues: Pharmacology and Functional Significance," Ann. Rev. Pharmacology & Toxicology, 27, 315-345 (1987; see particularly pp. 316-318.
Yount et al.; "Adenyl Imidodiphosphate, an Adenosine Triphosphate Analog Containing a P-N-P Linkage;" Biochemistry; vol. 10, No. 13; pp. 2484-2489 (1971).
Nielsen et al; "Sodium Imidodiphosphate. Synthesis, Identification and Hydrolytic Degradation;" Synthesis and Identification of Sodium Imidodiphosphate; vol. 83; pp. 99-102 (1961).
Murray et al.; "Adenosine 5'-Phosphorothioate. A Nucleotide Analog that is a Substrate, Competitive Inhibitor, or Regulator of Some Enzymes that Interact with Adenosine 5'-Phosphate;" Adenosine 5-Phosphorothioate as an AMP Analog; vol. 7, No. 11; pp. 4023-4029 (1968).
Fischer et al.; "Identification of Potent, Selective P.sub.2Y -Purinoceptor Agonists: Structure-Activity Relationships for 2-Thioether Derivatives of Adenosine 5'-Triphosphate;" J. Med. Chem; vol. 36; pp. 3937-3946 (1993). Agonist and Radioligand for the Receptor that Inhibits the Accumulation of Cyclic AMP in Intact Blood Platlets;" J. Chem. Invest.; vol. 71; pp. 420-425 (1983).
Watson, et al.; The G-Protein Linked Receptor FactsBook; pp. 30-31 (1994).
Fukunaga et al.; "Hypotensive Effects of Adenosine and Adenosine Triphosphate Compared with Sodium Nitroprusside;" Anesthesia and Analgesia; vol. 61, No. 3, pp. 273-278 (1982).
Barry, W.H., and Smith, T.W., "Mechanisms of Transmembrane Calcium Movement in Cultured Chick Embryo Ventricular Cells", J. Physiol. 1982, 325, 243-260.
Burnstock, G., et al., "Structure Activity Relationships for Derivatives of Adenosine-5'-Triphosphate as Agonists at P.sup.2 Purinoceptors: Heterogeneity Within P.sup.2x and P.sup.2Y Subtypes", Drug Development Research 1994, 31, 206-219.
Gui, J., Lane, W.S. Fu, X. -D., "A Serine Kinase Regulates Intracellular Localization of Splicing Factors in the Cell Cycle", Nature 1994, 369, 678-682.
Hoffman, B. and Bigger, "Digitalis and Allied Cardiac Glycosides", Chap. 34 in The Pharmacological Basis of Therapeutics, Gilman, A.G. et al., eds., Pergamon Press, 1990, pp. 814-839.
Kelly, R.A., Eid, H., Kramer, B.K., O'Neill, M., Liang, B.T., Reers, M., Smith, T.W., "Endothelin Enhances the Contractile Responsiveness of Adult Rat Ventricular Myocytes to Calcium by a Pertussis Toxin-Sensitive Pathway", J. Clin. Invest. 1990, 86, 1164-1171.
Kikugawa, K., et al., "Platelet Aggregation Inhibitors. IX. Chemical Transformation of Adenosine into 2-Thioadenosine Derivatives", Chem. Pharm. Bull. 1977 25, 1959-1969.
Kovacs, T., et al., "Simple Synthesis of 5-vinyl-and 5-ethynyl-2'-deoxyuridine-5'-triphosphates", Tetrahedron Letters 1988, 29(36), 4525-4528.
Munson, P. and Rodbard, "LIGAND: A Versatile Computerized Approach for Characterization of Ligand-Binding Systems", Analytical Biochemistry 1980, 107, 220-239.
Novgorodov, S. et al., "Expression of Porcine Leukocyte 12-lipoxygenase in a Baculovirus-insect Cell System and its Characterization", Arch. Biochem. Biophys. 1994, 312, 219-226.
Podrasky, E. et al., "Positive Inotropic Effect Mediated by a Novel Stimulatory P.sup.2Y -Like Purinergic Receptor in Cultured Fetal Ventricular Myocyte", The FASEB J. 1994, 8(5), 3686.
Rotrosen, D., Yeung, C., Katkin, J., "Production of Recombinant Cytochrome b558 Allows Reconstitution of the Phagocyte NADPH Oxidase Solely from Recombinant Proteins", J. Biol. Chem. 1993, 268, 14256-14260.
Sen, L., Liang, B.T., Colucci, W.S., Smith, T.W., "Enhanced .alpha.1-adrenergic Responsiveness in Cardiomypoathic Hamster Cardiac Myocytes: Relation to the Expression of Pertussis Toxin-sensitive G Protein and .alpha.1-adrenergic Receptors", Circ. Res. 1990, 67, 1182-1192.
Xu, H., Miller, J. and Liang, B.T., "High-efficiency Gene Transfer into Cardiac Myocytes", Nucleic Acids Research 1992, 20(23), 6425-6426.
Xu, D., Kong, H., Liang, B.T., "Expression and Pharmacological Characterization of a Stimulatory Subtype of Adenosine Receptor in Ventricular Myocyte", Circ. Res. 1992, 70, 56-65.
Zheng, J. -S. et al., "Extracellular Adenosine-Triphosphate (ATP Inhibits Cardiac Myocyte Hypertrophy Induced by Adrenergic Agonists", Circulation 1994, 90(4), 1039.
Crane L. Eric
Kight John
The Trustees of the University of Pennsylvania
LandOfFree
Inotropic ADP and ATP analogues and their pharmaceutical composi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inotropic ADP and ATP analogues and their pharmaceutical composi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inotropic ADP and ATP analogues and their pharmaceutical composi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342379